Cardiac MRI in Immune Checkpoint Inhibitor Associated Pericarditis

Can Öztürk1, Julian A Luetkens2,3

  • 1Department of Cardiology Heart Center University Hospital Bonn Bonn Germany.

Clinical Case Reports
|October 20, 2021
PubMed

Insights

Checkpoint inhibitors show promise in cancer treatment but can cause acute pericarditis, a dangerous heart condition. Cardiac MRI can detect this cardiotoxicity without harmful radiation or contrast dye.

Area of Science:

  • Oncology
  • Cardiology
  • Radiology

Background:

  • Checkpoint inhibitors are revolutionary cancer therapies.
  • Chemotherapy-associated cardiotoxicity, particularly acute pericarditis, presents a significant risk with up to 21% mortality.
  • Early detection of cardiotoxicity is crucial for patient management.

Purpose of the Study:

  • To highlight the diagnostic capabilities of Cardiac MRI for chemotherapy-associated cardiotoxicity.
  • To present Cardiac MRI as a safe and effective alternative to traditional imaging methods.

Main Methods:

  • Utilizing Cardiac MRI for comprehensive cardiac assessment.
  • Focusing on the detection of acute pericarditis as a key indicator of cardiotoxicity.
  • Emphasizing the non-invasive nature of Cardiac MRI, avoiding nephrotoxic contrast agents and ionizing radiation.

Main Results:

  • Cardiac MRI provides precise detection of chemotherapy-associated cardiotoxicity.
  • The technique effectively identifies acute pericarditis.
  • Cardiac MRI offers a safe alternative, eliminating risks associated with contrast dye and radiation.

Conclusions:

  • Cardiac MRI is a valuable tool for diagnosing cardiotoxicity in patients receiving cancer therapy.
  • This imaging modality offers a safe, radiation-free, and contrast-free method for cardiac assessment.
  • Cardiac MRI enhances patient safety by mitigating risks associated with chemotherapy side effects.

Related Concept Videos

Imaging Studies for Cardiovascular System IV: CMRI01:21

Imaging Studies for Cardiovascular System IV: CMRI

Cardiovascular magnetic resonance imaging, or CMRI, is a non-invasive diagnostic test that employs a magnetic field and radiofrequency waves to create precise images of the heart and arteries. It provides comprehensive information about cardiac anatomy, function, perfusion, and tissue characterization without ionizing radiation.IndicationsCMRI diagnoses various heart conditions, including tissue damage from heart attacks, ischemic heart disease, myocarditis, aortic issues (tears, aneurysms,...
156
Pericarditis II: Clinical Features and Diagnostic Tests01:19

Pericarditis II: Clinical Features and Diagnostic Tests

Pericarditis is distinguished by inflammation of the pericardium, the fibrous sac that encases the heart. It can be acute, lasting less than six weeks, or chronic, persisting for over three months. Understanding its clinical manifestations and diagnostic findings is crucial for timely and effective management.Clinical ManifestationsWhile pericarditis can be asymptomatic, it usually presents with characteristic symptoms such as:Chest Pain: The most characteristic symptom of pericarditis is chest...
58
Imaging Studies for Cardiovascular System V: CT01:28

Imaging Studies for Cardiovascular System V: CT

Cardiac computed tomography (CT) scanning is an advanced cardiac imaging technique that utilizes CT technology, with or without intravenous (IV) contrast, to produce accurate cross-sectional virtual slices of specific areas of the heart, coronary circulation, and major blood vessels such as the aorta, pulmonary veins, and arteries. The computer processes these slices to generate three-dimensional images. Multidetector CT (MDCT) is a rapid form of CT scanning that captures multiple slices...
99
Pericarditis III: Medical Management01:17

Pericarditis III: Medical Management

The primary objectives of managing pericarditis are to determine the underlying cause, provide effective therapy for treatment and symptom relief, and promptly detect signs and symptoms of cardiac tamponade. The following outlines the essential aspects of medical management for pericarditis:ObjectivesDetermine the Cause: Identifying the underlying cause of pericarditis is crucial for targeted treatment. Causes include viral infections, autoimmune diseases, post-cardiac injury syndrome, and...
61
Myocarditis III: Medical Management01:14

Myocarditis III: Medical Management

Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
31
Myocarditis II: Clinical Features and Diagnostic Tests01:27

Myocarditis II: Clinical Features and Diagnostic Tests

Myocarditis is an inflammation of the heart muscle. The symptoms vary widely, encompassing asymptomatic presentations to severe, acute manifestations.Clinical PresentationAsymptomatic cases: In some instances, myocarditis may be asymptomatic, with the infection resolving without intervention. These cases often go undetected unless discovered incidentally through diagnostic imaging or tests conducted for other reasons.General Early Symptoms: Early symptoms of myocarditis are non-specific and can...
44